tislelizumab
beigene,novartis
['mibc', 'tislelizumab']
interim results from a multicenter clinical study of tislelizumab combined with gemcitabine and cisplatin as neoadjuvant therapy for patients with ct2-t4an0m0 #mibc. presentation by tianxin lin. #asco22 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology